News
The U.S. Department of Veterans Affairs is taking aim at homelessness and its related issues affecting America's veteran ...
June 15, 2025 - Sacramento, CA – In response to the Trump Administration’s move to provide deportation officials with the personal data of Medicaid enrollees, health care provider groups across ...
Merus initially surged on superior interim trial data, while Bicara Therapeutics tanked. Click here to find out why BCAX ...
3d
Cryptopolitan on MSNRipple sets bold five-year target to capture SWIFT transaction volume with XRPRipple CEO Brad Garlinghouse has predicted that XRP could take up to 14% of interbank messaging platform SWIFT transaction volume in the next five years. Garlinghouse shared this projection at the ...
Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...
Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further devel ...
Databricks CEO Ali Ghodsi lauds India's advanced digital infrastructure, surpassing many nations and fostering innovation in ...
President Trump told reporters this week that he would send letters to trading partners in the next week or two setting ...
“Under no pressure and no response to any protest, they offered themselves a $2 billion commitment to the Black community and Black entrepreneurs, and then after the inauguration of Donald Trump, ...
Tesla ( TSLA 5.66%) stock has tumbled 22% year to date amid a myriad of business and political headwinds, and Wall Street ...
TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results